Jason G. Newland, MD

Jason Newland, MD, Med, is division chief of Infectious Diseases and an associate investigator in the Center for Child Health Equity and Outcomes Research in the Abigail Wexner Research Institute at Nationwide Children’s. Dr. Newland is also professor at The Ohio State University and holds the Cramblett Endowed Chair in Pediatric Infectious Diseases.

Prior to joining Nationwide Children’s, Dr. Newland held the Schnuck Family Endowed Chair in Pediatric Infectious Diseases at St. Louis Children’s Hospital and Washington University. He has authored more than 200 peer-reviewed publications and abstracts and is active in multiple professional societies and organizations, including the American Academy of Pediatrics and the Pediatric Infectious Diseases Society. His current research includes leading a multicenter AHRQ R01-funded study on the best strategies to eliminate unnecessary postoperative antibiotics.

Dr. Newland’s research interests are focused on the establishment and impacts of antimicrobial stewardship programs in children’s hospitals, helping to create guidelines for antibiotic use to treat infections appropriately while minimizing antibiotic-related complications as well as antimicrobial resistance. In 2013, Dr. Newland co-founded the Sharing Antimicrobial Reports for Pediatric Stewardship (SHARPS) Collaborative, a national collaboration of over 60 children’s hospitals dedicated to the appropriate use of antibiotics for children. He also co-directed the Antimicrobial Stewardship Council through BJC Healthcare from 2017 to 2023 and was the antimicrobial stewardship program director at St. Louis Children’s Hospital from 2016-2020. During the COVID-19 pandemic, Dr. Newland led efforts to evaluate the rate of transmission in school in collaboration with the Centers for Disease Control and Prevention. Most recently, he has been appointed the vice-chair of the US Presidential Advisory Council on Combating Antibiotic Resistant Bacteria.